ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 1600 Patients' Access to Treatments Act HR 6 21st Century Cures/Innovation for Healthier Americans HR 1859/S2782 Physician Workforce/Pediatric Subspecialty Loan Repayment Biosimilars guidance, oversight FDA HR 2029 National Defense Authorization Act National Pain Strategy Step Therapy Osteoarthritis Research
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Director, Health Policy and Federal Affairs |
| SANDIE J. PREISS | Vice President, Advocacy and Access |
Medicare/Medicaid MMM
Medicare Part B and D Telemedicine Medicaid CHIP CHIP Re-authorization S.776 Medication Therapy Management Empowerment Act of 2015 HR 2624/S1488 Part D Beneficiary Appeals Fairness Act Part B proposal HR5122
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Director, Health Policy and Federal Affairs |
| SANDIE J. PREISS | Vice President, Advocacy and Access |
Budget/Appropriations BUD
FY 17 appropriations for HHS, CDC, NIH, DOD, FDA, VA Budget Control Act Bipartisan Budget Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA HYDE | Director, Health Policy and Federal Affairs |
| SANDIE J. PREISS | Vice President, Advocacy and Access |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.